Connecting clinical care, data and research
PartnershipsContact
← Back to publications

RESEARCH PUBLICATION / 2025

Original Article

Long-term thyroid outcomes after COVID-19 vaccination

Long-Term Thyroid Outcomes After COVID-19 Vaccination: A Cohort Study of 2 333 496 Patients From the TriNetX Network.

The Journal of clinical endocrinology and metabolism

Citation & Authors

J Clin Endocrinol Metab. 2025;110(10):e3366-e3375.

Kai-Lun Cheng; Wei-Shin Yu; Yu-Hsun Wang; Gema Hernández Ibarburu; Hsiang-Lin Lee; James Cheng-Chung Wei

ABSTRACT · RESEARCH SUMMARY

Research summary

The matched TriNetX study compared approximately 1.167 million vaccinated and 1.167 million unvaccinated individuals. Subacute thyroiditis did not differ significantly. Hyperthyroidism risk was lower at 3–9 months after vaccination but did not differ at 12 months; hypothyroidism risk was higher at 6–12 months. Directions were not fully consistent across follow-up windows and vaccine subgroups, and these observational associations should not be interpreted as causal effects of vaccination.

Key points based on the public abstract; this is a reading guide, not a full abstract translation.Read original abstract ↗